公开(公告)号：US10744077B2

公开(公告)日：2020-08-18

申请号：US16053893

申请日：2018-08-03

Applicant: Colgate-Palmolive Company

Inventor： Lisa Manus ,  Julia Dreifus

IPC: A61Q11/00 ,  A61K8/88 ,  A61K8/27 ,  A61K8/362 ,  G01N33/50 ,  A61K8/44 ,  A61K8/21 ,  A61K8/70 ,  A61K8/81

Abstract: This invention relates to oral care compositions comprising arginine, zinc citrate and zinc oxide, and an orally acceptable carrier, as well as to methods of using and of making these compositions.

公开(公告)号：US20180344596A1

公开(公告)日：2018-12-06

申请号：US16053893

申请日：2018-08-03

Applicant: Colgate-Palmolive Company

Inventor： Lisa Manus ,  Julia Dreifus

IPC: A61K8/27 ,  A61K8/88 ,  A61K8/21 ,  A61K8/362 ,  A61K8/44 ,  A61K8/70 ,  A61Q11/00 ,  G01N33/50

Abstract: This invention relates to oral care compositions comprising arginine, zinc citrate and zinc oxide, and an orally acceptable carrier, as well as to methods of using and of making these compositions.

公开(公告)号：US11806416B2

公开(公告)日：2023-11-07

申请号：US16924254

申请日：2020-07-09

Applicant: Colgate-Palmolive Company

Inventor： Lisa Manus ,  Julia Dreifus

IPC: A61K8/27 ,  A61Q11/00 ,  G01N33/50 ,  A61K8/70 ,  A61K8/88 ,  A61K8/21 ,  A61K8/81 ,  A61K8/44 ,  A61K8/362

CPC classification number: A61K8/27 ,  A61K8/21 ,  A61K8/362 ,  A61K8/44 ,  A61K8/70 ,  A61K8/88 ,  A61Q11/00 ,  G01N33/50 ,  A61K8/8152 ,  A61K8/8164

Abstract: This invention relates to oral care compositions comprising arginine, zinc citrate and zinc oxide, and an orally acceptable carrier, as well as to methods of using and of making these compositions.

公开(公告)号：US10058493B2

公开(公告)日：2018-08-28

申请号：US15386031

申请日：2016-12-21

Applicant: COLGATE-PALMOLIVE COMPANY

Inventor： Lisa Manus ,  Julia Dreifus

IPC: A61Q11/00 ,  A61K8/88 ,  A61K8/27 ,  A61K8/362 ,  G01N33/50 ,  A61K8/44 ,  A61K8/21 ,  A61K8/70 ,  A61K8/81

CPC classification number: A61K8/27 ,  A61K8/21 ,  A61K8/362 ,  A61K8/44 ,  A61K8/70 ,  A61K8/8152 ,  A61K8/8164 ,  A61K8/88 ,  A61Q11/00 ,  G01N33/50 ,  Y10S514/901

Abstract: This invention relates to oral care compositions comprising arginine, zinc citrate and zinc oxide, and an orally acceptable carrier, as well as to methods of using and of making these compositions.